1. Home
  2. BVS vs SPOK Comparison

BVS vs SPOK Comparison

Compare BVS & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • SPOK
  • Stock Information
  • Founded
  • BVS 2011
  • SPOK 2004
  • Country
  • BVS United States
  • SPOK United States
  • Employees
  • BVS N/A
  • SPOK N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SPOK Telecommunications Equipment
  • Sector
  • BVS Health Care
  • SPOK Telecommunications
  • Exchange
  • BVS Nasdaq
  • SPOK Nasdaq
  • Market Cap
  • BVS 432.7M
  • SPOK 379.1M
  • IPO Year
  • BVS 2021
  • SPOK 1992
  • Fundamental
  • Price
  • BVS $7.63
  • SPOK $17.91
  • Analyst Decision
  • BVS Strong Buy
  • SPOK Hold
  • Analyst Count
  • BVS 5
  • SPOK 1
  • Target Price
  • BVS $14.40
  • SPOK $15.00
  • AVG Volume (30 Days)
  • BVS 542.4K
  • SPOK 169.3K
  • Earning Date
  • BVS 08-06-2025
  • SPOK 07-30-2025
  • Dividend Yield
  • BVS N/A
  • SPOK 6.99%
  • EPS Growth
  • BVS N/A
  • SPOK 10.71
  • EPS
  • BVS 0.03
  • SPOK 0.83
  • Revenue
  • BVS $564,142,000.00
  • SPOK $140,742,000.00
  • Revenue This Year
  • BVS N/A
  • SPOK $2.26
  • Revenue Next Year
  • BVS $6.26
  • SPOK $2.54
  • P/E Ratio
  • BVS $277.70
  • SPOK $21.55
  • Revenue Growth
  • BVS 5.08
  • SPOK 1.79
  • 52 Week Low
  • BVS $5.81
  • SPOK $13.55
  • 52 Week High
  • BVS $14.38
  • SPOK $19.31
  • Technical
  • Relative Strength Index (RSI)
  • BVS 62.12
  • SPOK 48.67
  • Support Level
  • BVS $7.03
  • SPOK $17.61
  • Resistance Level
  • BVS $7.48
  • SPOK $18.23
  • Average True Range (ATR)
  • BVS 0.43
  • SPOK 0.37
  • MACD
  • BVS 0.05
  • SPOK -0.10
  • Stochastic Oscillator
  • BVS 94.49
  • SPOK 26.05

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: